市場調查報告書
商品編碼
1439261
全球機械循環輔助設備市場:洞察、競爭格局、市場預測:2030 年Mechanical Circulatory Support Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球機械循環輔助設備市場規模為24.7億美元。 預計到 2030 年,該市場將達到 42.4 億美元,2024 年至 2030 年的預測期間複合年增長率為 9.44%。 機械循環支援設備的需求主要由心血管疾病(CVD)盛行率上升、心血管疾病(CVD)危險因子增加、產品組合技術進步、心臟捐贈者短缺以及在預測期內推動。由其他人推動。
根據美國心臟協會2022的數據,2020年全球約有2.441億人將患有冠狀動脈心臟病(缺血性)心臟病。 同一消息來源稱,2020年,北非、中東、中亞和南亞以及中歐和東歐是全球冠心病(缺血性)心臟病患病率最高的地區。
根據英國心臟基金會 2022 年版數據,2019 年全球約有 5.5 億人(每 14 人中就有 1 人)患有心臟和循環系統疾病。其中包括約 2.9 億女性和 2.6 億男性。
肥胖、高血壓、糖尿病、吸煙、高齡、飲酒、不健康的生活方式、動脈粥樣硬化等危險因素的增加是心血管疾病發生的主要原因,機械循環支持設備市場我們正在進一步推動生長。
根據世界衛生組織資料(2023),2020年,全球約有10億人年齡在60歲以上。 到2050年,60歲及以上的人口預計將增加一倍,達到約21億人。 此外,預計 2020 年至 2050 年間,80 歲及以上的人口數量將增加兩倍,達到 4.26 億人。
本報告研究了全球機械循環輔助設備市場,並提供了市場概述,包括按產品、最終用戶、地區和參與市場的公司概況劃分的趨勢。
Mechanical Circulatory Support Devices Market By Product (Ventricular Assist Devices [Left Ventricular Assist Device, Right Ventricular Assist Device, and Biventricular Assist Device], Artificial Heart, Extracorporeal Membrane Oxygenation, and Intra-Aortic Balloon Pump), End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Cardiology Centers), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of cardiovascular diseases
The global mechanical circulatory support devices market was valued at USD 2.47 billion in 2023, growing at a CAGR of 9.44% during the forecast period from 2024 to 2030, to reach USD 4.24 billion by 2030. The demand for mechanical circulatory support devices is primarily motivated by a rise in cardiovascular disease (CVDs) prevalence, an increasing number of risk factors for cardiovascular diseases (CVDs), technological advancements in the product portfolio, scarcity of heart donors, and others during the forecast period.
Mechanical Circulatory Support Devices Market Dynamics:
According to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020. As per the same source, North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of coronary (ischemic) heart disease in the world in 2020.
As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.
The increasing number of risk factors such as obesity, hypertension, diabetes, smoking, old age, alcohol consumption, unhealthy lifestyle, atherosclerosis, and others is the main reason for the development of cardiovascular diseases further driving the market growth for mechanical circulatory support devices.
According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.
However, high treatment costs and limitations regarding the safety of implantable devices may prove to be certain restraints to the mechanical circulatory support devices market growth.
Mechanical Circulatory Support Devices Market Segment Analysis:
Mechanical Circulatory Support Devices by Product (Ventricular Assist Devices [Left Ventricular Assist Device, Right Ventricular Assist Device, and Biventricular Assist Device], Artificial Heart, Extracorporeal Membrane Oxygenation, and Intra-Aortic Balloon Pump), End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Cardiology Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the mechanical circulatory support devices market product segment, under the ventricular assist devices segment, the left ventricular assist device category is expected to hold the largest share and is one of the fastest-growing segments in this market.
This is primarily attributed to technological advancements, the scarcity of organ donors, and the increasing prevalence of heart failure globally. The technologically advanced features like the smaller size enable it to be implanted with minimal invasion to provide complete ventricular circulation assistance and reduced hemolysis by providing ample path for circulation, thus accounting for the largest shareholder in the market.
Mechanical circulatory support (MCS) with left ventricular assist devices (LVAD) is a safe and efficacious treatment strategy for patients with end-stage heart failure (HF) that is refractory to medical therapy, with >22 000 devices implanted to date in America and >2500 new implants occurring annually.
Technological advances in left ventricular assist devices (LVAD), including continuous flow technology, have aided in improving implantability and efficiency; providing extended support helps in creating demand for these devices, thereby contributing to the growth of the mechanical circulatory support devices market.
Additionally, assistance from government bodies, and favorable reimbursement scenarios, are expected to enhance the mechanical circulatory support devices market potential in several countries. Hence, all the above-mentioned factors are expected to drive the segment growth.
North America is expected to dominate the Overall Mechanical Circulatory Support Devices Market:
North America is expected to dominate the overall Mechanical Circulatory Support Devices market during the forecast period. This domination is due to the growing prevalence of chronic diseases in the region, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others.
For instance, the American Heart Association in 2021 projected that by 2035, more than 130 million US adults will have some type of heart disease.
According to the Centers for Disease Control and Prevention (CDC) 2022, around 18.2 million people aged 20 or above have coronary artery disease in the US.
As per the above-mentioned source, around 805,000 people face heart attacks every year with 605,000 people facing it for the first time and about 200,000 having at least one incident of a heart attack before.
Thus, the increasing prevalence of various cardiovascular diseases will increase the demand for mechanical circulatory support devices in the North American region, during the forecast period from 2024-2030.
Mechanical Circulatory Support Devices Market Key Players:
Some of the key market players operating in the mechanical circulatory support devices market include Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, and others.
Recent Developmental Activities in the Mechanical Circulatory Support Devices Market:
In October 2020, the US Food and Drug Administration (FDA) granted 510(k) clearance to Abiomed for an all-in-one, compact extracorporeal membrane oxygenation (ECMO) cardiopulmonary bypass system called the Abiomed Breethe OXY-1 System.
Key Takeaways from the Mechanical Circulatory Support Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global mechanical circulatory support devices market.
Various opportunities are available for the other competitor in the mechanical circulatory support devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for mechanical circulatory support devices market growth in the coming future?
Target Audience who can be benefited from this Mechanical Circulatory Support Devices Market Report Study
Mechanical Circulatory Support Devices providers
Research organizations and consulting companies
Mechanical Circulatory Support Devices related to organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in mechanical circulatory support devices
Various End-Users want to know more about the mechanical circulatory support devices market and the latest technological developments in the mechanical circulatory support devices market.
Frequently Asked Questions for Mechanical Circulatory Support Devices Market:
Mechanical Circulatory Support Devices are devices that replace or assist the pumping function of the ventricles. These devices support the functioning of a weak heart by pumping blood. They can be used as a bridge to transplantation, for destination therapy, or as a bridge to recovery postcardiotomy.
The global mechanical circulatory support devices market was valued at USD 2.47 billion in 2023, growing at a CAGR of 9.44% during the forecast period from 2024 to 2030, to reach USD 4.24 billion by 2030.
The major drivers driving the demand for mechanical circulatory support devices are rising technological advancement, the growing burden of cardiovascular diseases, and the increasing geriatric population.
Some of the key market players operating in the mechanical circulatory support devices market include Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, and others.
North America is expected to dominate the overall mechanical circulatory support devices market during the forecast period, 2024 to 2030. This domination is due to the growing demand for advanced technologies in mechanical circulatory support devices, and the increasing chronic disease in the region.